Growing community of inventors

Bordeaux, France

Arnau Busquet-Garcia

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Arnau Busquet-GarciaPier Vincenzo Piazza (2 patents)Arnau Busquet-GarciaJean-Michel Revest (2 patents)Arnau Busquet-GarciaGiovanni Marsicano (2 patents)Arnau Busquet-GarciaDaniela Cota (2 patents)Arnau Busquet-GarciaStéphanie Monlezun (2 patents)Arnau Busquet-GarciaMathilde Metna (2 patents)Arnau Busquet-GarciaMonique Vallee (1 patent)Arnau Busquet-GarciaSandy Fabre (1 patent)Arnau Busquet-GarciaMonique Vallée (1 patent)Arnau Busquet-GarciaSandy Fabre (1 patent)Arnau Busquet-GarciaSandy Fabre (1 patent)Arnau Busquet-GarciaStephanie Monlezun (1 patent)Arnau Busquet-GarciaArnau Busquet-Garcia (2 patents)Pier Vincenzo PiazzaPier Vincenzo Piazza (6 patents)Jean-Michel RevestJean-Michel Revest (5 patents)Giovanni MarsicanoGiovanni Marsicano (4 patents)Daniela CotaDaniela Cota (4 patents)Stéphanie MonlezunStéphanie Monlezun (2 patents)Mathilde MetnaMathilde Metna (2 patents)Monique ValleeMonique Vallee (4 patents)Sandy FabreSandy Fabre (2 patents)Monique ValléeMonique Vallée (1 patent)Sandy FabreSandy Fabre (1 patent)Sandy FabreSandy Fabre (5 patents)Stephanie MonlezunStephanie Monlezun (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitë De Bordeaux (2 from 211 patents)

2. Aelis Farma (2 from 2 patents)

3. Institut National De La Sante Et De La Recherche Medicale (1 from 1,744 patents)

4. Inserm (Institut National De La Sante Et De La Recherche Medicale) (1 from 40 patents)

5. Inserm (0 patent)


2 patents:

1. 12447159 - 3β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related Disorders

2. 11484537 - 3β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/6/2026
Loading…